Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, et al. Global multi-stakeholder endorsement of the MAFLD definition. Lancet Gastroenterol Hepatol. 2022;7(5):388–390

Article  PubMed  Google Scholar 

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209

Article  PubMed  Google Scholar 

Eslam M, Sanyal AJ, George J, International Consensus P. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014

Article  CAS  PubMed  Google Scholar 

Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology (Baltimore, MD). 2021;73(3):1194–1198

Article  PubMed  Google Scholar 

Lim S, Kim JW, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2021;32(7):500–514

Article  CAS  PubMed  Google Scholar 

Driessen S, Francque SM, Anker SD, Castro Cabezas M, Grobbee DE, Tushuizen ME, et al. Metabolic dysfunction associated steatotic liver disease and the heart. Hepatology. 2023. https://doi.org/10.1097/HEP.0000000000000735

Article  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–1986

Article  PubMed  Google Scholar 

Maestri M, Santopaolo F, Pompili M, Gasbarrini A, Ponziani FR. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: effects of current treatments and future strategies. Front Nutr. 2023;10:1110536

Article  PubMed  PubMed Central  Google Scholar 

Rodrigues SG, van der Merwe S, Krag A, Wiest R. Gut-liver axis: pathophysiological concepts and medical perspective in chronic liver diseases. Semin Immunol. 2024;71:101859

Article  PubMed  Google Scholar 

Luo L, Chang Y, Sheng L. Gut-liver axis in the progression of nonalcoholic fatty liver disease: from the microbial derivatives-centered perspective. Life Sci. 2023;321:121614

Article  CAS  PubMed  Google Scholar 

Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut-liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol. 2023;20(7):447–461

Article  PubMed  Google Scholar 

Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533

Article  PubMed  PubMed Central  Google Scholar 

de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020–1032

Article  PubMed  Google Scholar 

Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–141

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the healthy gut microbiota composition? a changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65:330–339

Article  PubMed  Google Scholar 

Tovoli F, Negrini G, Farì R, Guidetti E, Faggiano C, Napoli L, et al. Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors. Aliment Pharmacol Ther. 2018;48(5):538–546

Article  CAS  PubMed  Google Scholar 

Raiteri A, Granito A, Faggiano C, Giamperoli A, Catenaro T, Negrini G, et al. Hepatic steatosis in patients with celiac disease: the role of packaged gluten-free foods. Nutrients. 2022;14(14):2942

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2013;62(12):1787–1794

Article  PubMed  Google Scholar 

Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. 2020;17(5):279–297

Article  PubMed  Google Scholar 

Barber TM, Hanson P, Weickert MO. Metabolic-associated fatty liver disease and the gut microbiota. Endocrinol Metab Clin North Am. 2023;52(3):485–496

Article  PubMed  Google Scholar 

Abenavoli L, Scarlata GGM, Scarpellini E, Boccuto L, Spagnuolo R, Tilocca B, et al. Metabolic-dysfunction-associated fatty liver disease and gut microbiota: from fatty liver to dysmetabolic syndrome. Medicina (Kaunas). 2023;59(3):594

Article  PubMed  Google Scholar 

Su X, Chen S, Liu J, Feng Y, Han E, Hao X, et al. Composition of gut microbiota and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Obes Rev. 2024;25(1):e13646

Article  CAS  PubMed  Google Scholar 

Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol Hepatol. 2021;11(5):1463–1482

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forlano R, Mullish BH, Roberts LA, Thursz MR, Manousou P. The intestinal barrier and its dysfunction in patients with metabolic diseases and non-alcoholic fatty liver disease. Int J Mol Sci. 2022;23(2):662

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xin D, Zong-Shun L, Bang-Mao W, Lu Z. Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease. Hepatogastroenterology. 2014;61(129):136–140

PubMed  Google Scholar 

Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49(6):1877–1887

Article  CAS  PubMed  Google Scholar 

Kaushal K, Agarwal S, Sharma S, Goswami P, Singh N, Sachdev V, et al. Demonstration of gut-barrier dysfunction in early stages of non-alcoholic fatty liver disease: a proof-of-concept study. J Clin Exp Hepatol. 2022;12(4):1102–1113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fianchi F, Liguori A, Gasbarrini A, Grieco A, Miele L. Nonalcoholic fatty liver disease (NAFLD) as model of gut-liver axis interaction: from pathophysiology to potential target of treatment for personalized therapy. Int J Mol Sci. 2021;22(12):6485

Article  CAS  PubMed  PubMed Central  Google Scholar 

Da Silva HE, Teterina A, Comelli EM, Taibi A, Arendt BM, Fischer SE, et al. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Sci Rep. 2018;8(1):1466

Article